Cargando…
Critical COVID‐19 is associated with distinct leukocyte phenotypes and transcriptome patterns
BACKGROUND: Prognostic markers for disease severity and identification of therapeutic targets in COVID‐19 are urgently needed. We have studied innate and adaptive immunity on protein and transcriptomic level in COVID‐19 patients with different disease severity at admission and longitudinally during...
Autores principales: | Christensen, E. E., Jørgensen, M. J., Nore, K. G., Dahl, T. B., Yang, K., Ranheim, T., Huse, C., Lind, A., Nur, S., Stiksrud, B., Jenum, S., Tonby, K., Holter, J. C., Holten, A. R., Halvorsen, B., Dyrhol‐Riise, A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242786/ https://www.ncbi.nlm.nih.gov/pubmed/34080738 http://dx.doi.org/10.1111/joim.13310 |
Ejemplares similares
-
Severely ill COVID-19 patients have altered circulating levels of proteins controlling the epitranscriptome()
por: Quiles-Jiménez, A., et al.
Publicado: (2023) -
Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in Mycobacterium tuberculosis Infection and Disease
por: Nore, Kristin Grotle, et al.
Publicado: (2020) -
Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure
por: Ueland, T, et al.
Publicado: (2020) -
Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2021) -
Monocytic myeloid‐derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase‐2 inhibitors
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2020)